RNSSL displays the many weapons in its arsenal to 4Ps B&M
Money grows on the tree of persistence! And Rane NSK Steering Systems Limited’s (RNSSL) persistence (in supplying steering systems) over the years has proven this Japanese adage to be true. Rising input costs and lower profitability have hit the automotive industry where it hurts the most. But as an exception, RNSSL with their breath taking technology is surging ahead steadily with sheer determination of making its mark and ‘steering’ the industry.
In 1997, RNSSL kicked off as a 50:50 JV
between Rane group (India) and NSK Ltd (Japan) with an equity capital of Rs.179 million. Today, it boasts of manufacturing plants in Chennai and Bawal (Haryana). The company has pumped in Rs.377 million in the recently opened Bawal plant which has an annual production capacity of two lakh electric power steering systems. “We have decided to invest in this plant keeping in mind with our overall strategic growth plans. RNSSL will grow in its chosen segments through expansion, upgraded technology and synergetic diversification,” says L. Ganesh, Chairman, Rane Group.
The company has done well on the balance sheet too. Over the last 3-5 years they have recorded a CAGR of 20% in terms of revenues and have won numerous awards including Gold award from Frost & Sullivan and Zero PPM award from Toyota in 2007.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2008
Money grows on the tree of persistence! And Rane NSK Steering Systems Limited’s (RNSSL) persistence (in supplying steering systems) over the years has proven this Japanese adage to be true. Rising input costs and lower profitability have hit the automotive industry where it hurts the most. But as an exception, RNSSL with their breath taking technology is surging ahead steadily with sheer determination of making its mark and ‘steering’ the industry.
In 1997, RNSSL kicked off as a 50:50 JV
between Rane group (India) and NSK Ltd (Japan) with an equity capital of Rs.179 million. Today, it boasts of manufacturing plants in Chennai and Bawal (Haryana). The company has pumped in Rs.377 million in the recently opened Bawal plant which has an annual production capacity of two lakh electric power steering systems. “We have decided to invest in this plant keeping in mind with our overall strategic growth plans. RNSSL will grow in its chosen segments through expansion, upgraded technology and synergetic diversification,” says L. Ganesh, Chairman, Rane Group.The company has done well on the balance sheet too. Over the last 3-5 years they have recorded a CAGR of 20% in terms of revenues and have won numerous awards including Gold award from Frost & Sullivan and Zero PPM award from Toyota in 2007.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2008
n that Indian pharma companies have lost their appetite? Or is it capital constraints giving them hiccups? “No”, says Anindya Acharya, Deputy Director, Drugs and Pharmaceuticals, CII. “It’s a well planned strategic move by the Indian pharma companies targeted towards improving their portfolios by entering certain niche segments rather than gobbling-up the entire portfolio of the prey.” Certainly, domestic pharma market is going through a transformation phase, led by strong underlying growth drivers and has witnessed robust growth over the last couple of years. According to a KPMG-CII Pharma Summit 2007 Report, the industry has grown at a CAGR of 13% from 2002-2007 and is further expected to grow at over 16% over 2007-2011. So there’s no dearth of future growth in the sector.